We are live on
!
Find out more
DAM
DLD Asset Management Portfolio holdings
AUM
$1.51B
Turnover
51.11%
1-Year Est. Return
5.32%
This Fund
S&P 500
This Quarter
Est. Return
+0.48%
1 Year Est. Return
+5.32%
3 Year Est. Return
+10.27%
5 Year Est. Return
+32.59%
10 Year Est. Return
–
AUM
$1.38B
AUM Growth
+$362M
(+36%)
Cap. Flow
-$348M
Cap. Flow
% of AUM
-25.31%
Top 10 Holdings %
Top 10 Hldgs %
62.01%
Holding
142
New
43
Increased
15
Reduced
9
Closed
60
Avg Time Held Equity + Options
0.2
years
Top 10 Avg Time Held Equity + Options
0.4
years
Top 20 Avg Time Held Equity + Options
0.3
years
Avg Time Held Equity only
0.2
years
Top 10 Avg Time Held Equity only
0.4
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$53.1M |
| 2 |
KSU
Kansas City Southern
KSU
|
+$31.9M |
| 3 |
PF
Pinnacle Foods, Inc.
PF
|
+$27.7M |
| 4 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$5.3M |
| 5 |
Pacira BioSciences
PCRX
|
+$3.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTC Therapeutics
PTCT
|
+$12.3M |
| 2 |
Insmed
INSM
|
+$7.51M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$6.36M |
| 4 |
Vistra Energy Corp.
DYNC
|
+$5.07M |
| 5 |
Neighborhood Intelligence Inc
NXH
|
+$3.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 89.94% |
| 2 | Technology | 3.93% |
| 3 | Industrials | 2.49% |
| 4 | Consumer Staples | 2.13% |
| 5 | Healthcare | 0.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
KSU
1
PUT
DELISTED
Kansas City Southern
KSU
| $195M | 14.16% |
+1,852,900
| New | +$198M |
2017 Q4
0 quarters
|
|
|
2
PUT
Cognizant
CTSH
$29.5B
| $88.6M | 6.44% |
+1,247,500
| New | +$91.2M |
2017 Q4
0 quarters
|
|
3
CALL
NXP Semiconductors
NXPI
$57.2B
| $66.7M | 4.84% |
569,600
+224,300
| +65% | +$25.9M |
2017 Q1
3 quarters
|
|
|
PF
4
PUT
DELISTED
Pinnacle Foods, Inc.
PF
| $60.5M | 4.39% |
+1,016,500
| New | +$57.3M |
2017 Q4
0 quarters
|
|
|
5
Cognizant
CTSH
$29.5B
| $51.6M | 3.75% |
+726,740
| New | +$53.1M |
2017 Q4
0 quarters
|
|
6
PUT
Infosys
INFY
$49.3B
| $43.3M | 3.14% |
+5,334,800
| New | +$40.6M |
2017 Q4
0 quarters
|
|
|
LCI
7
PUT
DELISTED
Lannett Company, Inc.
LCI
| $41.6M | 3.02% |
448,825
+364,000
| +429% | +$35.5M |
2017 Q3
1 quarter
|
|
|
KSU
8
DELISTED
Kansas City Southern
KSU
| $31.5M | 2.29% |
+299,125
| New | +$31.9M |
2017 Q4
0 quarters
|
|
|
PF
9
DELISTED
Pinnacle Foods, Inc.
PF
| $29.2M | 2.12% |
+491,817
| New | +$27.7M |
2017 Q4
0 quarters
|
|
|
IMMU
10
CALL
DELISTED
Immunomedics Inc
IMMU
| $28.5M | 2.07% |
1,763,300
+1,043,000
| +145% | +$12.3M |
2017 Q1
3 quarters
|
|
11
PUT
KRONOS Worldwide
KRO
$859M
| $27.6M | 2.01% |
+1,071,700
| New | +$28.1M |
2017 Q4
0 quarters
|
|
|
IMMU
12
PUT
DELISTED
Immunomedics Inc
IMMU
| $23.7M | 1.72% |
1,468,300
+846,500
| +136% | +$9.99M |
2017 Q2
2 quarters
|
|
|
13
PUT
NXP Semiconductors
NXPI
$57.2B
| $19.5M | 1.42% |
167,000
+1,400
| +0.8% | +$162K |
2017 Q2
2 quarters
|
|
14
PUT
Intel
INTC
$497B
| $18.5M | 1.34% |
400,000
| – | – |
2017 Q2
2 quarters
|
|
|
MNK
15
PUT
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $17.5M | 1.27% |
+776,600
| New | +$20.8M |
2017 Q4
0 quarters
|
|
|
16
CALL
Neighborhood Intelligence Inc
NXH
$186M
| $16.6M | 1.21% |
1,315,694
-506,445
| -28% | -$18.3M |
2017 Q3
1 quarter
|
|
17
PUT
ANI Pharmaceuticals
ANIP
$1.67B
| $15.3M | 1.11% |
236,700
+54,200
| +30% | +$3.37M |
2016 Q4
4 quarters
|
|
18
CALL
NLI Holdings
NL
$338M
| $10.7M | 0.78% |
+748,700
| New | +$9.5M |
2017 Q4
0 quarters
|
|
|
EGOV
19
PUT
DELISTED
NIC Inc
EGOV
| $6.99M | 0.51% |
+421,700
| New | +$7.12M |
2017 Q4
0 quarters
|
|
20
CALL
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.12M | 0.44% |
+422,700
| New | +$6.53M |
2017 Q4
0 quarters
|
|
|
LCI
21
CALL
DELISTED
Lannett Company, Inc.
LCI
| $6.09M | 0.44% |
+65,725
| New | +$6.41M |
2017 Q4
0 quarters
|
|
|
IVC
22
PUT
DELISTED
Invacare Corporation
IVC
| $4.92M | 0.36% |
291,200
-42,100
| -13% | -$685K |
2017 Q2
2 quarters
|
|
23
PUT
DELISTED
Dermira, Inc.
DERM
| $4.89M | 0.36% |
176,000
+55,900
| +47% | +$1.48M |
2017 Q3
1 quarter
|
|
|
SCMP
24
PUT
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $4.89M | 0.36% |
+272,000
| New | +$3.35M |
2017 Q4
0 quarters
|
|
|
MNK
25
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $4.46M | 0.32% |
+197,682
| New | +$5.3M |
2017 Q4
0 quarters
|
|
Similar funds
FFM
AWA
SC
HCM
NB
WFA
RIM
AU
DLD Asset Management's Q4 2017 Portfolio in Review
As of Q4 2017, DLD Asset Management held 142 positions worth $1.38B, up 36% from $1.02B the previous quarter. Its ten largest holdings account for 62% of the portfolio.
DLD Asset Management withdrew a net $348M in Q4 2017, closing 60 positions and reducing 9 holdings. Its most notable exit was PTC Therapeutics, an estimated $12.3M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 90% of assets, down from 95% a quarter earlier, followed by Technology and Industrials.
Against the trend, DLD Asset Management opened a new position in Cognizant worth $51.6M.
- DLD Asset Management's largest Q4 2017 buy was Cognizant: 726,740 shares worth $51.6M.
- DLD Asset Management added most to Otonomy, Inc. in Q4 2017, an estimated $1.16M increase.
- DLD Asset Management's biggest Q4 2017 reduction was Lipocine, cutting an estimated $1.03M.
- DLD Asset Management fully exited PTC Therapeutics in Q4 2017, selling an estimated $12.3M.
- DLD Asset Management's ten largest holdings make up 62% of its $1.38B portfolio in Q4 2017.
- DLD Asset Management opened 43 new positions and closed 60 in Q4 2017.
- DLD Asset Management's portfolio value rose 36% quarter-over-quarter to $1.38B.
Based on DLD Asset Management's 13F filing for Q4 2017, filed 12 Feb 2018.